Keith Publications Logo Keith Publications
  Cluster 3: Health, Medicine & Life Sciences

Journals for Drug Discovery Research (2026)

Drug discovery research — encompassing target identification, lead compound screening, medicinal chemistry optimisation, structure-activity relationships, ADME characterisation, and early-stage preclinical pharmacology — generates findings that form the foundation of pharmaceutical drug development. Journals for drug discovery research need to accommodate the full spectrum from computational methods to laboratory pharmacology, and Keith Publications JPBR serves this niche effectively.

Submit Your Manuscript Browse All Topics

What to Look for When Choosing a Journal

Before submitting your research, evaluate journals on these key criteria:

  • Specialist scope — journal explicitly covers your niche health or medical domain
  • Editorial board with deep expertise in your specific health subdiscipline
  • Published articles demonstrating the depth of coverage in your area
  • Indexing that reaches your target audience of specialists and practitioners
  • Open access to ensure practitioners in your niche domain can access findings
  • Fast review — specialist reviewers reduce back-and-forth revision delays

Recommended Journals — Cluster 3: Health, Medicine & Life Sciences

All journals below are published by Keith Publications — open access, peer-reviewed, and indexed for global discoverability.

  • Health Sciences and Medical Research Journal (HSMRJ)

    Health sciences, clinical medicine, public health, epidemiology, biomedical research, and interdisciplinary studies advancing human health outcomes.

    Review: 2–4 weeks Open Access DOI (CrossRef) Google Scholar
    Health Sciences Clinical Medicine Public Health Epidemiology
  • Columbia Journal of Medicine and Healthcare (CJMH)

    Medical research, healthcare delivery, hospital management, clinical practice, health policy, and translational medicine bridging research and patient care.

    Review: 2–3 weeks Open Access DOI (CrossRef) Google Scholar
    Medical Research Healthcare Delivery Clinical Practice Health Policy
  • Journal of Nursing and Allied Health Sciences (JNAHS)

    Nursing practice, allied health professions, patient care, clinical nursing research, health education, and evidence-based practice across healthcare settings.

    Review: 2–4 weeks Open Access DOI (CrossRef) Google Scholar
    Nursing Practice Allied Health Patient Care Health Education
  • Journal of Pharmacology and Biomedical Research (JPBR)

    Pharmacology, drug discovery, biomedical sciences, life sciences, oncology, biochemistry, and molecular medicine with clinical and applied relevance.

    Review: 2–4 weeks Open Access DOI (CrossRef) Google Scholar
    Pharmacology Drug Research Biomedical Sciences Life Sciences

Fast Publication: All Keith Publications journals complete initial review within 2–5 business days and full peer review within 2–4 weeks. Articles are published online within 5–10 days of acceptance — making us one of the fastest open access publishers in the health sciences and medicine field.

Why Specialist Health Journals Matter

Specialist health journals serve a critical function — they provide dedicated homes for highly specialised medical and health research that might not receive adequate attention in broad-scope publications. A paper on pharmacogenomics in oncology, nurse-led diabetes management, or traditional plant medicine pharmacology will find a more engaged readership and more expert peer review in a journal that actively covers these topics. Keith Publications health journals are designed to accommodate both specialist research and interdisciplinary health studies that cross traditional specialty boundaries.

Interdisciplinary Health Research and Publication

Many of the most important health research advances today sit at disciplinary intersections — pharmacology and genomics, nursing and digital health, public health and behavioural science, oncology and immunotherapy, traditional medicine and pharmacology. Finding the right journal for interdisciplinary health research can be challenging. Keith Publications health and medical journals are built to handle this complexity, with editorial boards drawn from multiple health disciplines and a broad publishing model that accommodates research spanning traditional medical specialty boundaries — ensuring your interdisciplinary findings reach the widest possible audience of researchers and clinicians.

Tips to Maximise Your Acceptance Chances

  1. Align your topic with the journal's scope — read the aims and scope carefully before submitting.
  2. Write a compelling abstract — clearly state your research question, methodology, key findings, and clinical or scientific significance.
  3. Ensure ethical compliance — include ethics committee approval, patient consent, and clinical trial registration details where applicable.
  4. Follow reporting guidelines — use CONSORT, STROBE, CARE, PRISMA, or other relevant Equator Network standards for your study design.
  5. Use current and relevant references — cite recent publications alongside seminal works in your health sciences discipline.
  6. Follow formatting guidelines exactly — non-compliant manuscripts are often desk-rejected without peer review.
  7. State practical implications — explain how your health or medical findings can improve patient care or inform health policy.

Frequently Asked Questions

Which journals publish drug discovery research at Keith Publications?
The Journal of Pharmacology and Biomedical Research (JPBR) is the primary Keith Publications journal for drug discovery research — covering target identification, natural product discovery, lead compound optimisation, structure-activity relationships, molecular docking, and early-stage pharmacological profiling.
Is computer-aided drug design research accepted in drug discovery journals?
Yes. Computational drug discovery — molecular docking, QSAR modelling, virtual screening, molecular dynamics simulation, and pharmacophore modelling — is within scope for Keith Publications JPBR when applied to identifying or optimising pharmacologically relevant compounds.
Can fragment-based drug discovery research be published?
Yes. Fragment-based drug discovery, including fragment library screening, fragment linking strategies, and structural biology-guided fragment optimisation studies, is within scope for the Journal of Pharmacology and Biomedical Research (JPBR).
What natural product screening data is sufficient for drug discovery publication?
For natural product drug discovery: plant extract preparation and characterisation, primary biological screening results with dose-response data, initial toxicity assessment, and preliminary mechanism-of-action studies constitute a publishable drug discovery manuscript. Compound isolation and structural elucidation data strengthen submissions significantly.

Ready to Publish Your Research?

Submit your health sciences, medical, nursing, or life sciences manuscript to Keith Publications today. Fast peer review, open access, and global indexing — get your work published within weeks.

Submit Your Manuscript Now Contact the Editorial Team